The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Friedewald-Estimated Versus Directly Measured Low-Density Lipoprotein Cholesterol and Treatment Implications
Open accessAbstract
Objectives The aim of this study was to compare Friedewald-estimated and directly measured low-density lipoprotein cholesterol (LDL-C) values.Background LDL-C is routinely estimated by the Friedewald equation to guide treatment; however, compatibility with direct measurement has received relatively little scrutiny, especially at levels <70 mg/dl now targeted in high-risk patients.Methods We examined 1,340,614 U.S. adults who underwent lipid profiling by vertical spin density gradient ultracentrifugation (Atherotech, Birmingham, Alabama) from 2009 to 2011. Following standard practice, Friedewald LDL-C was not estimated if triglyceride levels were ≥ 400 mg/dl (n = 30,174), yielding 1,310,440 total patients and 191,333 patients with Friedewald LDL-C <70 mg/dl.Results Patients were 59 ± 15 years of age and 52% were women. Lipid distributions closely matched those in the National Health and Nutrition Examination Survey. A greater difference in the Friedewald-estimated versus directly measured LDL-C occurred at lower LDL-C and higher triglyceride levels. If the Friedewald-estimated LDL-C was <70 mg/dl, the median directly measured LDL-C was 9.0 mg/dl higher (5th to 95th percentiles, 1.8 to 15.4 mg/dl) when triglyceride levels were 150 to 199 mg/dl and 18.4 mg/dl higher (5th to 95th percentiles, 6.6 to 36.0 mg/dl) when triglyceride levels were 200 to 399 mg/dl. Of patients with a Friedewald-estimated LDL-C <70 mg/dl, 23% had a directly measured LDL-C ≥ 70 mg/dl (39% if triglyceride levels were concurrently 150 to 199 mg/dl; 59% if triglyceride levels were concurrently 200 to 399 mg/dl).Conclusions The Friedewald equation tends to underestimate LDL-C most when accuracy is most crucial. Especially if triglyceride levels are ≥ 150 mg/dl, Friedewald estimation commonly classifies LDL-C as <70 mg/dl despite directly measured levels ≥ 70 mg/dl, and therefore additional evaluation is warranted in high-risk patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This may erroneously exclude > 20% of patients for initiation or intensification of lipid-lowering therapy [45].”
From Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM (2020) · cites this paper as [45]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“At very low LDLC concentration ranges < 1.8 mmol/L, in which VLDLC constitutes a relatively larger fraction of the blood cholesterol, VLDLC overestimation at high TG concentration > 2.3 mmol/L introduces a more significant error in the calculation of cLDLC [45].”
From Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM (2020) · cites this paper as [45]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The use of the Martin-Hopkins method provides a more accurate assessment of LDL-C in individuals with hypertriglyceridemia (38,39).”
From 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia (2021) · cites this paper as [38]
Experimental — accuracy not yet measuredIn the citing paper
“For the general population, calculated LDL-C and direct LDL-C show very strong correlations [80-83].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [80]
In the citing paper
“Nonetheless, the committee acknowledges that there can be significant discrepancies in levels of directly measured versus calculated LDL-C within the same sample, especially at lower LDL-C levels (19,20).”
In the citing paper
“This risk is accelerated in the presence of other ASCVD risk factors(18,19).”
In the citing paper
“Patients with baseline elevation of LDL-C $190 mg/dL not due to secondary modifiable causes are at very high risk of first and recurrent ASCVD events because of their lifetime exposure to markedly elevated LDL-C levels.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
ESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
Grundy, S. M., Cleeman, J. I., Bairey Merz, C. N., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.001 · Cited by 1,550
Smith, S. C., Benjamin, E. J., Bonow, R. O., Braun, L. T., Creager, M. A., Franklin, B. A., Gibbons, R. J., Grundy, S. M., Hiratzka, L. F., Jones, D. W., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.10.824 · Cited by 918
Genest, J. J., McPherson, R., Frohlich, J. J., Anderson, T. J., Campbell, N. R. C., Carpentier, A. C., Couture, P., Dufour, R., Fodor, G. J., Francis, G. A., et al. (2009) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(09)70715-9 · Cited by 765
ESC/EAS Guidelines for the management of dyslipidaemias
Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.028 · Cited by 706
Flagged first, then by citations
Research works printed but not linked: 1
- Li, 2011, Surveillance of certain health behaviors and conditions among states and selected local areas, MMWR Surveill Summ, 60, 1
Cited by
Sorted by citations
Items 301–400 of 428
Thapa, S., Gyawali, P., Bhatt, R. D., & Risal, P. (2020) · Journal of Pathology of Nepal · doi:10.3126/jpn.v10i1.27163 · Cited by 3
Leitão, A. E., Vieira, M. D. C. S., Gomes, D. A., Boing, L., Pelegrini, A., Luiz, E., & Guimarães, A. C. D. A. (2021) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2020.101301 · Cited by 3
Lipid Levels in Refugees from Burma
Weinmann, A., Fontaine, P. L., Loth, K. A., & Luepker, R. V. (2021) · Journal of Community Health · doi:10.1007/s10900-021-00990-5 · Cited by 3
Sojit, T. O. M. O., Sankanagoudar, S., & SHUKLA, R. K. (2022) · Minerva Endocrinology · doi:10.23736/s2724-6507.22.03697-1 · Cited by 3
Genetically Low Triglycerides and Mortality: Further Support for “the Earlier the Better”?
Martin, S. S., & Blaha, M. J. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2013.220970 · Cited by 3
Self-citationLee, J. S., Lee, H., Cha, H., Seok, J., & Jeong, I. C. (2025) · PLoS ONE · doi:10.1371/journal.pone.0327169 · Cited by 2
“However, accumulated evidence [7–10] suggests that even at TG levels 400 mg/dL, the formula tends to underestimate LDL-C in individuals with elevated TG concentrations, particularly when such individuals are classified into lower LDL-C treatment categories [9–14].”
Doku, R., Osafo, N. Y. A., Kwagyan, J., & Southerland, W. M. (2026) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfag098 · Cited by 2
Development and Validation of a Simplified Martin-Hopkins LDL-C Equation Using Machine Learning
Park, J., Fan, L., Marzinke, M. A., Sokoll, L. J., Muthukumar, A., Murphy, S. A., Sabatine, M. S., Gurudu, R., Meeusen, J. W., & Martin, S. S. (2026) · JAMA Cardiology · doi:10.1001/jamacardio.2026.2314 · Cited by 2
Self-citationSarkar, G. C., Paul, S. K., Chakrabortty, R., Ahmed, S., Islam, S., Paul, S. C., Dhar, D., Alam, K., Choudhury, S. A. R. A., Rayhan, M. A., et al. (2023) · Bangabandhu Sheikh Mujib Medical University Journal · doi:10.3329/bsmmuj.v15i4.64151 · Cited by 3
Yu, S., Sun, H. Y., & Yoo, B. W. (2023) · Journal of Yeungnam Medical Science · doi:10.12701/jyms.2023.00528 · Cited by 2
“This formula is known to become less accurate as TG levels increase, especially when LDL-C is 70 mg/dL [32,33].”
BackgroundPorat, O., Kaplan, M., Atlibenkin, S., Hasson-Gilad, D. R., Karban, A., & Zalts, R. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02022-2 · Cited by 2
“The TG/5 term serves as an estimation of very low-density lipoprotein-cholesterol (VLDL-C), but its accuracy diminishes at TG levels over 177 mg/dL [4].”
BackgroundNuwaylati, D. A., & Awan, Z. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-55921-w · Cited by 2
Márk, L., Fülöp, P., Lőrincz, H., Dani, G., Tajtiné, K. F., Thury, A. Á., & Paragh, G. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13123398 · Cited by 2
“As TG levels above 2.3 mmol/L may significantly interfere with LDL-F [27], we also used the Martin–Hopkins method (LDL-MH) [24] at the index event and 6 and 12 months after to compare them with LDL-F.”
MethodInfluentialDyslipidemia: recommendations for diagnosis and treatment at the first level of medical contact
Acevedo, M. D. L. B., Abdo-Francis, M., Aguilar-Salinas, C. A., Balcázar‐Hernández, L., Borrayo–Sánchez, G., Castro‐Narro, G., Chávez-Negrete, A. J., Díaz-Aragón, A., Enciso‐Muñoz, J. M., Fernández-Barros, C. L., et al. (2024) · Gaceta Médica de México · doi:10.24875/gmm.m24000916 · Cited by 2
Gijón‐Conde, T., Banegas, J. R., Sánchez, C. F., Rodrigo Alonso, K., & Mata, P. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120400 · Cited by 2
Highlights of the Year in JACC 2013
DeMaria, A. N., ADLER, E. D., Bax, J. J., Ben‐Yehuda, O., Feld, G. K., Greenberg, B., Hall, J. L., Hlatky, M. A., Lew, W. Y. W., Lima, J. A. C., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.002 · Cited by 2
Lekskulchai, V. (2018) · Medical science monitor basic research/Medical science monitor. Basic research · doi:10.12659/msmbr.907751 · Cited by 2
“This finding was in accordance with previous reports [20,24,25], therefore, the underestimation of calculated LDL-C should be kept in mind when applying this treatment goal.”
ResultClinical profile of severe hypercholesterolemia in 156,000 adults in primary care
Gijón‐Conde, T., Sánchez, C. F., Delgado, I. I., Jiménez, B. R., & Banegas, J. R. (2024) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2024.01.003 · Cited by 3
Estimation of Mathematical Models Accuracy for Calculation of LDL-Cholesterol Concentration
Кузьменко, В. В., Gornov, A. Y., & Anikin, A. S. (2018) · International Workshop 'Critical Infrastructures: Contingency Management, Intelligent, Agent-Based, Cloud Computing and Cyber Security' (IWCI) · doi:10.2991/iwci-18.2018.20 · Cited by 2
“Friedewald [3, 4] is used in the laboratory.”
BackgroundKurniawan, L. B., Windarwati, W., & Mulyono, B. E. (2018) · INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY · doi:10.24293/ijcpml.v24i3.1339 · Cited by 2
Jagesh, R., John, M., Jalaja, M. M. N., Oommen, T., & Gopinath, D. (2020) · Indian Journal of Clinical Cardiology · doi:10.1177/2632463620978044 · Cited by 2
A Contemporary Evaluation of Calculated and Directly Measured LDL
Lau, C. S., Loh, W. J., Phua, S. K., & Aw, T. C. (2021) · Japan Journal of Clinical & Medical Research · doi:10.47363/jjcmr/2021(1)109 · Cited by 1
Ishida, H., Yamamoto, Y., Saito, M., Ishihara, Y., Fujita, T., Ishida, M., Kato, Y., Nohisa, Y., Matsunami, H., Takemura, M., et al. (2022) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/00045632221098870 · Cited by 2
Alternative equations for the calculation of LDL cholesterol: Is it time to replace Friedewald?
Boot, C. S., & Luvai, A. (2022) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/00045632221119104 · Cited by 2
Sahi, N., Pandya, N. A., & Modi, R. B. (2024) · International Journal of Advanced Biochemistry Research · doi:10.33545/26174693.2024.v8.i5b.1079 · Cited by 1
“Their analysis found a mean difference of -23.0 mg/dl, with limits of agreement ranging from -72.4 mg/dl to 26.4 mg/dl [17] .”
BackgroundInfluentialLipids, Lipoproteins, and Cardiovascular Outcomes
Sakers, A. P., Mszar, R., & Soffer, D. E. (2024) · Contemporary cardiology · doi:10.1007/978-3-031-54960-1_9 · Cited by 1
Isoje, E. F., Okoro, I. O., Apiamu, A., & Okpoghono, J. (2025) · Food Chemistry Advances · doi:10.1016/j.focha.2025.101049 · Cited by 1
Reiber, I., Márk, L., Lőrincz, H., Együd, F., Mező, I., & Paragh, G. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14145003 · Cited by 1
“For F-LDL-C, we used the formula TC–HDL-C–TG/2.2 [6]; for MH-LDL-C, the formula was TC–HDL-C − TG/(TG and non-HDL-C dependent ratios) [7]; and for S-LDL-C, the formula was (TC/0.948) − (HDL-C/0.971) − ((TG/8.56) + (TGxnon-HDL-C/2140) − (TG 2 /16100)) − 9.44 [8,9].”
InfluentialMachulsky, N. F., Jacobsen, D., Madaf, A. C., Fochi, A., Gomez, M. E., & Berg, G. A. (2025) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfaf204 · Cited by 1
Capece, U., Iacomini, C., Morciano, C., Gugliandolo, S., Splendore, A., Cesario, A., Masciocchi, C., Giuseppe, G. D., Ciccarelli, G., AVOLIO, A., et al. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.04.018 · Cited by 1
Atashak, S., Stannard, S. R., Guerra-Balic, M., Montané, J., Oviedo, G. R., Santamaría, G., Roche, E., Mielgo‐Ayuso, J., Miguel, A. M., Fernández‐Lázaro, D., et al. (2026) · Exploration of Endocrine and Metabolic Diseases · doi:10.37349/eemd.2026.101469 · Cited by 1
Lipids in Coronary Heart Disease
Martin, S. S., Joshi, P. H., & Michos, E. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802385-3.00007-3 · Cited by 2
Self-citationUsing the VAP lipid panel for the detection, evaluation, and treatment of patients “at risk” for CAD
French, K., Wang, Y., Jia, J., & Zhang, Y. (2017) · Frontiers in Laboratory Medicine · doi:10.1016/j.flm.2017.11.001 · Cited by 1
Sherhan, A. A., & Omran, A. (2017) · The Medical Journal of Basrah University · doi:10.33762/mjbu.2017.126394 · Cited by 1
“[13] Some researchers look for other way to predict the atherogenic lipids.”
BackgroundManases, T., Kengne, A. P., Mefo’o, J. P. N., Mboue-Djieka, Y., Dimala, C. A., & Choukem, S. P. (2018) · Pan African Medical Journal Conference Proceedings · doi:10.11604/pamj.cp.2017.2.33.67 · Cited by 1
A rare presentation of type 1 diabetes mellitus
Ateko, O. A., Lawal, Y., Reng, R. S., Ugwuneji, U. O., Julius, I. U., & Anumah, F. E. (2022) · The Journal of Clinical and Scientific Research · doi:10.4103/jcsr.jcsr_44_21 · Cited by 1
Awan, Z. A., & Nuwaylati, D. A. (2022) · Journal of Applied Hematology · doi:10.4103/joah.joah_48_22 · Cited by 1
Arrobas, T., Guijarro, C., Campuzano, R., Piñero, M. R., Marcos, J. F. V., López, A. M. B., López, A. M., López, A. M., Donaire, J. A. G., Obaya, J. C., et al. (2023) · REC CardioClinics · doi:10.55783/rcmf.160106 · Cited by 8
“colesterol y triglicéridos totales (por métodos enzimáticos) y la determinación directa del colesterol HDL. La 34 de Friedewald es la utilizada con más frecuencia .”
BackgroundConsensus document for lipid profile determination and reporting in Spanish clinical laboratories
Velilla, T. A., Guijarro, C., Ruíz, R. C., Piñero, M. R., Marcos, J. F. V., Pérez, A., López, M. A. B., López, A. M., Donaire, J. A. G., Obaya, J. C., et al. (2023) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2023.05.001 · Cited by 1
“34 Friedewald's formula for the estimation of LDL cholesterol (in mg/dL) Friedewald's formula assumes the absence of chylomi-crons and a specific of cholesterol/Tg ratio in VLDL (1/5 in mg/dL; 1/2.”
Consensus document for lipid profile testing and reporting in Spanish clinical laboratories
Velilla, T. A., Guijarro, C., Ruíz, R. C., Piñero, M. R., Marcos, J. F. V., Pérez, A., López, M. A. B., López, A. M., Donaire, J. A. G., Obaya, J. C., et al. (2023) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2023.06.001 · Cited by 1
Lowhalidanon, K., & Khunkaewla, P. (2023) · Monoclonal Antibodies in Immunodiagnosis and Immunotherapy · doi:10.1089/mab.2023.0009 · Cited by 1
“30”
Pottegård, A., Gerdes, L. U., Wetche, J. L., & Thompson, W. (2024) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvae043 · Cited by 1
“11 , 12 This could lead to undertreatment in regions where risk calculators include LDL -C.”
BackgroundBolat, S., Yerlitaş, S. İ., Cephe, A., Koçhan, N., Zararsız, G. E., Doğan, H. O., & Zararsız, G. (2024) · Cumhuriyet Science Journal · doi:10.17776/csj.1452125 · Cited by 1
Demircan, G., Özel, D., Özel, B. D., Özkan, F., Halefoğlu, A. M., Özel, A., & Ozbey, F. R. (2016) · SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital · doi:10.5350/semb.20160107014832 · Cited by 1
“Son dönemde 200’e kadar olan değerler normal, 200-240 mg/dl sınırda yüksek, 240 mg/dl ve üstü yüksek kolesterol olarak tanımlanmaktadır (11).”
Brown, W. V., Handelsman, Y., Martin, S. S., & Morris, P. B. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.04.113 · Cited by 1
Self-citationSendhav, S. S., Chatterjee, B., Kakaiya, A., & Biswas, P. C. (2018) · International Journal of Clinical Biochemistry and Research · doi:10.18231/2394-6377.2018.0115 · Cited by 1
HAART Use and Cardiovascular Risk Among HIV Patients in Rivers State, Nigeria
Oluwabunmi, A. A., Nnedinma, O. S., & Odia, J. O. (2019) · Cardiology and Cardiovascular Research · doi:10.11648/j.ccr.20190303.11 · Cited by 1
Ferrari, D., Motta, A., Strollo, M., & Locatelli, M. (2020) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v91i3.8980 · Cited by 1
“Despite economically convenient, the Friedewald calculation is prone to inaccuracies at high triglyceride levels (>400 mg/dL) but also at low LDLC levels (13, 14).”
BackgroundKeti, D. B., & Muhtaroğlu, S. (2021) · Revista română de medicină de laborator · doi:10.2478/rrlm-2021-0007 · Cited by 1
Pillay, T., Rossouw, H. M., Steyn, N., & Carelse, A. (2023) · South African Medical Journal · doi:10.7196/samj.2024.v114i1.1573 · Cited by 1
Stone, N. J. (2016) · Circulation · doi:10.1161/circulationaha.116.025794 · Cited by 1
Tesfa, E., Munshea, A., Nibret, E., Mekonnen, D. S., Sinishaw, M. A., & Gizaw, S. T. (2023) · Research Square · doi:10.21203/rs.3.rs-2404370/v1 · Cited by 1
Understanding Lipid Measurement Error to Improve Cardiovascular Risk
Stone, N. J., & Blum, C. B. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad120 · Cited by 1
Harahsheh, A. S., Clauss, S. B., & Mietus‐Snyder, M. (2014) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-014-0381-x
Corral, P. (2014) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2014.07.001
Grobler, C. J. (2015) · DUT Open Scholar (Durban University of Technology) · doi:10.51415/10321/1421
LaRosa, J. C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.027
Elevated Triglycerides, Atherosclerosis and Adverse Clinical Events
Jones, S. R., & Nakhla, S. (2015) · Springer eBooks · doi:10.1007/978-3-319-20415-4_5
Self-citationQuispe, R., Martin, S. S., & Jones, S. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-42982-3_12
Self-citationMeasurement of Lipoproteins: Upping the Game in Characterizing the Lipid Phenotype
Collinson, P. O. (2016) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2016.021279
Low-Density Lipoprotein Measurement Discordance
Intwala, S., Stone, N. J., & Balady, G. J. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.0256
HIGH SENSITIVITY CARDIAC TROPONIN-T IS ASSOCIATED WITH INCIDENT HYPERTENSION
McEvoy, J. W. (2015)
Self-citationEleryan, M. G., Akhiyat, S., Awosika, O., Wenk, K. S., Rengifo‐Pardo, M., Martin, L. W., & Ehrlich, A. (2018) · Journal of Psoriasis and Psoriatic Arthritis · doi:10.1177/2475530318781329
Lagisetty, L., & Darapuneni, R. C. (2020) · Journal of Medical and Scientific Research · doi:10.17727/jmsr.2020/8-2
“[5] Martin SS, Blaha MJ, Elshazly MB, Brinton EA, Toth PP, et al.”
BackgroundOrringer, C. E., & Stone, N. J. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56514-5_6
Zhuang, C., Wang, Q., Wang, W.-J., Sun, R., Zhang, X., & Yu, J. (2021) · Research Square · doi:10.21203/rs.3.rs-230193/v1
“Because the measurement of LDL-C can be in uenced by increased TG in cardiovascular risk assessment [61], an appropriate way to estimate the amount of apoB-containing lipoprotein is the determination of nonHDL-C [62].”
BackgroundChang, L., Chen, X., & Ye, Z. (2021) · Research Square · doi:10.21203/rs.3.rs-229857/v1
“the Friedewald equation, can be inaccurate[21].”
Mendes, G. A., Azevedo, M. E., & Andrade, T. C. (2021) · Programa de Iniciação Científica - PIC/UniCEUB - Relatórios de Pesquisa · doi:10.5102/pic.n0.2019.7533
Chang, L., Chen, X., & Lian, C. (2021) · Research Square · doi:10.21203/rs.3.rs-700309/v1
Krishna, B., Tejaswi, P. S. P., Krishna, D. N. R., Dhas, P. K., Sree, K. S., & Ilanchezhian, T. (2021) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2021.v69i02.018
Effect of Palm Oil, Palm Olein, Palm Kernel Oil and Their Blends on the Lipid Profile of Albino Rats
Imoisi, O. B., Ezoguan, V. O., & Imafidon, M. I. (2021) · Journal of applied science and environmental management · doi:10.4314/jasem.v25i8.21
Padugupati, S., Ramamoorthy, S., Thangavelu, K., Sarma, D., & Jamadar, D. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns2.6256
“LDL-C was calculated by using Friedewald formula [35-39].”
MethodÇizmecioğlu, A., Göktepe, M. H., Çizmecioğlu, H. A., Bıyık, Z., Yavuz, Y. C., & Altıntepe, L. (2022) · Genel Tıp Dergisi · doi:10.54005/geneltip.1041116
Vargas‐Vázquez, A., Bello‐Chavolla, O. Y., Antonio‐Villa, N. E., Mehta, R., Cruz‐Bautista, I., & Aguilar-Salinas, C. A. (2021) · Research Square · doi:10.21203/rs.3.rs-249674/v1
Faculty Opinions recommendation of Repositioning of the Global Epicentre of Non-Optimal Cholesterol.
Fazio, S. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738066204.793575448
Padugupati, S., Ramamoorthy, S., Thangavelu, K., Sarma, D., & Jamadar, D. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns6.10100
“LDL-C was calculated by using Friedewald formula [35-39].”
MethodNon-high-density lipoprotein cholesterol and treatment targets in vascular surgery patients
Braet, D. J., Pourak, K., Mouli, V. H., Palmon, I., Dinh, D., Osborne, N. H., Vemuri, C., & Brandt, E. J. (2022) · Vascular · doi:10.1177/17085381221126232
Assessment of dyslipidemia among hypertensive pregnant women in Gaza Strip
Masad, A. A. (2017) · Israa University Journal for Applied Science · doi:10.52865/zdrq1624
Genetic lipid disorders, the APOE gene and Familial Dysbetalipoproteinemia
Heidemann, B. E. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/1408
Işıksaçan, N., Yıldız, C., Çağlar, F. N. T., Koşer, M., Atar, P., Bıyık, İ., Karabulut, D., & Ertürk, M. (2023) · Journal of Clinical Medicine of Kazakhstan · doi:10.23950/jcmk/12904
Velilla, T. A., Guijarro, C., Ruíz, R. C., Piñero, M. R., Marcos, J. F. V., Pérez, A., López, M. A. B., López, A. M., Donaire, J. A. G., Obaya, J. C., et al. (2023) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2022.12.002
Mora, S., & Martin, S. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88286-6.00003-0
Self-citationConsensus document for lipid profile testing and reporting in Spanish clinical laboratories
Velilla, T. A., Guijarro, C., Ruíz, R. C., Piñero, M. R., Marcos, J. F. V., López, A. M. B., López, A. M., Donaire, J. A. G., Obaya, J. C., Guerra, L. C., et al. (2023) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2023.05.012
Velilla, T. A., Guijarro, C., Ruíz, R. C., Piñero, M. R., Marcos, J. F. V., Pérez, A., López, M. A. B., López, A. M., Donaire, J. A. G., Obaya, J. C., et al. (2023) · Revista Clínica Española · doi:10.1016/j.rce.2022.11.001 · Cited by 1
Velilla, T. A., Guijarro, C., Ruíz, R. C., Piñero, M. R., Marcos, J. F. V., Pérez, A., López, M. A. B., López, A. M., Donaire, J. A. G., Obaya, J. C., et al. (2023) · Cirugía Cardiovascular · doi:10.1016/j.circv.2023.02.001
Statin Therapy: Impact on Dyslipidemia and Cardiovascular Events in Patients with Diabetes
Gudenkauf, B., Jones, S. R., & Martin, S. S. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_22
Self-citationVelilla, T. A., Guijarro, C., Ruíz, R. C., Piñero, M. R., Marcos, J. F. V., Pérez, A., López, M. A. B., López, A. M., Donaire, J. A. G., Obaya, J. C., et al. (2023) · Nefrología · doi:10.1016/j.nefro.2023.02.002 · Cited by 1
Velilla, T. A., Guijarro, C., Ruíz, R. C., Piñero, M. R., Marcos, J. F. V., Pérez, A., López, M. A. B., López, A. M., Donaire, J. A. G., Obaya, J. C., et al. (2023) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2023.02.002
周, 婕. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1381921
Hu, C., Huang, K., Cai, C., Liu, F., Li, J., Hu, D., Zhao, Y., Liu, X., Cao, J., Chen, S., et al. (2023) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003277
“The LDL-C levels were calculated with the Friedewald formula (20).”
MethodPerfil clínico de la hipercolesterolemia severa en 156.000 adultos en atención primaria
Gijón‐Conde, T., Sánchez, C. F., Delgado, I. I., Jiménez, B. R., & Banegas, J. R. (2023) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2023.08.002 · Cited by 1
Validating the NIH LDL-C equation for provincial implementation in Alberta
Higgins, V., Garcia, L., Gifford, J. L., Volodko, N., Beriault, D. R., Parker, M. L., Estey, M. P., Proctor, D. T., & Ismail, O. Z. (2023) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2023.110678
Dakouri, B. Y. K., Toure, A., Hauhouot, M.-L. A., Kacou-N'douba, A., & Karamoko, I. N. (2023) · International Journal of Clinical Biochemistry and Research · doi:10.18231/j.ijcbr.2023.038
Thompson‐Paul, A. M., Sekkarie, A., & Loustalot, F. V. (2023) · American Public Health Association eBooks · doi:10.2105/9780875533377ch14
Misurazione diretta del colesterolo-LDL e sue possibili conseguenze sulla terapia farmacologica
Cemin, R., Casablanca, S., Ermacora, D., & Daves, M. (2023) · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine · doi:10.23736/s1825-859x.23.00217-7
Щастный, А. Т., Осочук, А. С., Martsinkevich, A. F., & Стефанович, О. С. (2024) · Хирургия Восточная Европа · doi:10.34883/pi.2023.12.3.017
Higgins, V., Habeeb, N. W.-A., Bailey, D., Beriault, D. R., Blasutig, I. M., Collier, C. P., Venner, A. A., & Adeli, K. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.01.023
Metadata
- Authors
- Martin, S. S., Blaha, M. J., Elshazly, M. B., Brinton, E. A., Toth, P. P., McEvoy, J. W., Joshi, P. H., Kulkarni, K. R., Mize, P. D., Kwiterovich, P. O., DeFilippis, A. P., Blumenthal, R. S., & Jones, S. R.
- Affiliations
- Johns Hopkins University (US)
- Foundation for Biomedical Research (US)
- CGH Medical Center (US)
- University of Louisville (US)
- Corresponding author
- Martin, Seth S.
- ORCID
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 62
- Issue
- 8
- Pages
- 732-739
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2054299101
- Cited by
- 428
- References
- 23
- Citations by year
- 2026: 21 · 2025: 24 · 2024: 35 · 2023: 59 · 2022: 43 · 2021: 38 · 2020: 32 · 2019: 25 · 2018: 35 · 2017: 22 · 2016: 28 · 2015: 22 · 2014: 30 · 2013: 14
- FWCI
- 30.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Abbott Laboratories
- Merck & Co.
- Amarin Pharmaceuticals
- Health Diagnostics Laboratory
- Roche/Genentech
- Pfizer
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- Friedewald formula, LDL cholesterol estimation, direct LDL-C measurement, triglyceride levels, hypertriglyceridemia, lipidomics, dyslipidemia management, cardiovascular risk stratification
- MeSH terms
- Adult, Aged, Apolipoproteins B, Blood Chemical Analysis, Centrifugation, Density Gradient, Female, Humans, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Triglycerides, Reproducibility of Results, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
